Cryptocurrency Analysis and News Portal
The Moderna vaccine trial involved about 30,000 participants and the interim analysis for the vaccine was based on 95 infections among the trial participantsThe stock of an American biotechnology company that focuses on drug discovery, and drug development Moderna Inc (NASDAQ: MRNA) is soaring in today’s pre-market following reports that
Read More
Moderna COVID-19 vaccine candidate dubbed mRNA-1273 has entered its late-stage trials. The company noted that as of Wednesday, September 16, 2020, about 25,296 participants have been enrolled.The CEO of biotechnology company Moderna Inc (NASDAQ: MRNA) Stephane Bancel has disclosed the company will know whether its COVID-19 vaccine candidate will be
Read More
Moderna (MRNA) stock price is rising. The rally is fueled by the company’s announcement that its COVID-19 vaccine candidate produced neutralizing antibodies in all 45 participants.Moderna Inc (NASDAQ: MRNA) stock rose by 15.88% to $92.72 to retest the previous ATH. Investors in the company had something concrete to hold on
Read More